<DOC>
	<DOC>NCT00897169</DOC>
	<brief_summary>This trial is conducted in Europe and Japan. The aim of this clinical trial is to investigate the possible difference in the development of type 2 diabetes in a Japanese and a Caucasian population. Healthy subjects, subjects with impaired glucose tolerance, as well as subjects with type 2 diabetes will be included in the trial. The development of type 2 diabetes across the cohort will be investigated with regard to insulin sensitivity and B-cell capacity.</brief_summary>
	<brief_title>A Trial Investigating the Possible Difference in Development of Type 2 Diabetes Between Caucasian and Japanese Subjects</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus, Type 2</mesh_term>
	<criteria>Danish (Northern European) or Japanese (according to country allocation) background for at least 3 generations BMI above or equal to 18 kg/m2 Treatment of diabetes mellitus with any insulin product Fasting plasma/serum glucose above 12 mM Therapy with TZD (thiazolidinedione) drugs within the past 3 months Therapy with more than 2 OADs (oral antidiabetics drugs)</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>October 2016</verification_date>
</DOC>